Evidence map›Paper›PMID 30515678›Full record

Observational studyEndocrine2019

Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk.

Luca Degli Esposti, Anna Girardi, Stefania Saragoni, Stefania Sella, Margherita Andretta, Maurizio Rossini, Sandro Giannini, on the behalf of the Study group

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Endocrine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. State sequence analysis for a deeper understanding of treatment adherence patterns in fragility fracture patients.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Evaluating benefit from vitamin D supplementation: defining the area for treatment.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Intracapsular Femoral Neck Fractures in the Elderly.Revista brasileira de ortopedia · 2022
    Article
  18. Article
  19. Epidemiology and economic burden of fragility fractures in Austria.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Article
  20. How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Luca Degli EspostiCliCon S.r.l. Health, Economics & Outcomes Research, Ravenna, Italy. luca.degliesposti@clicon.it.
Anna GirardiCliCon S.r.l. Health, Economics & Outcomes Research, Ravenna, Italy.
Stefania SaragoniCliCon S.r.l. Health, Economics & Outcomes Research, Ravenna, Italy.
Stefania SellaDepartment of Medicine, Clinica Medica 1, University of Padova and Regional Center for Osteoporosis, Padova, Italy.
Margherita AndrettaUOC HTA, Azienda Zero-Regione Veneto, Verona, Italy.
Maurizio RossiniRheumatology Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
Sandro GianniniDepartment of Medicine, Clinica Medica 1, University of Padova and Regional Center for Osteoporosis, Padova, Italy.
on the behalf of the Study group
University of Padua · ITCenter for Outcomes Research and Clinical Epidemiology · ITAzienda Ospedaliera Universitaria Integrata Verona · IT

Funding

Abiogen SrL, Pisa Italy Not applicable
6 · The paper itself

Abstract

purposeTo evaluate the impact of pharmacological treatment in osteoporosis patients with recent fracture and to assess the incidence of subsequent fracture and all-cause mortality.

methodsThis observational retrospective study was based on data from administrative databases of five Italian Local Health Units. Osteoporosis patients aged ≥ 50 years with hospitalization for vertebral or hip fracture occurring between 01/01/2011 and 31/12/2015 were included. Treatment adherence was calculated using the medication possession ratio. Multivariable proportional hazard Cox model was used to identify factors associated with time to re-fracture and all-cause mortality.

resultsA cohort of 3475 patients were included and 41.5% of them did not receive any specific anti-fracture treatment. Among treated patients (N = 2032), the majority (83.6%) received calcium/vitamin D supplementation. Over a mean follow-up of 3 years, the risk of subsequent fractures was 44.4% lower in treated patients compared to untreated ones (HR = 0.556, 95% CI = 0.420-0.735, p < 0.001) and 64.4% lower in those receiving calcium/vitamin D supplementation compared to osteoporosis treatment only (HR = 0.356, 95% CI = 0.237-0.533, p < 0.001). The risk of re-fracture was 77.2% lower in treated patients who were adherent to medication (HR = 0.228, 95% CI = 0.139-0.376, p < 0.001). Treated patients had 64% lower mortality risk over the follow-up compared to untreated ones (HR = 0.360, 95% CI = 0.310-0.418, p < 0.001).

conclusionsA consistent proportion of osteoporosis patients did not receive specific treatment after a fracture, showing poor adherence to national guidelines on osteoporosis treatment. Osteoporosis drug treatment, and to a greater extent in combination with calcium/vitamin D, and adherence were correlated with lower risk of both re-fracture and all-cause mortality.

Indexed as

AgedAged, 80 and overBone Density Conservation AgentsCalciumFemaleHumansMaleMedication AdherenceMiddle AgedOsteoporosisOsteoporotic FracturesRecurrenceRetrospective StudiesRiskSecondary PreventionVitamin DBone Density Conservation AgentsCalciumVitamin DCalcium/vitamin DClinical settingOsteoporosisRe-fracture riskTreatment patterns

Identifiers

PMID30515678
OpenAlexW2902905442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.